Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States February 2023

Rao, A., Schrodt, C., Minhaj, F., et al. (2023). Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023. Morbidity and Mortality Weekly Report (MMWR). 72(9):232–243.
The report provides updated clinical treatment considerations about using therapeutic countermeasures to treat severe mpox cases.
Rate:
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.